A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

This study has been terminated.

(Financing and re-organization)

Sponsor:

Information provided by (Responsible Party):

Galectin Therapeutics Inc.

ClinicalTrials.gov Identifier:

NCT00388700

First received: October 13, 2006

Last updated: March 13, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2009
Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)